Joanne Shields
Overview
Explore the profile of Joanne Shields including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blair C, Shields J, Mullan R, Johnston W, Davenport A, Fouque D, et al.
Int J Nurs Stud Adv
. 2024 Sep;
7:100235.
PMID: 39328835
Background: Chronic kidney disease is common, affecting up to 13 % of the global population, and is predicted to become the fifth leading cause of 'life years lost' by 2040....
2.
Sun X, McKeaveney C, Shields J, Chan C, Henderson M, Fitzell F, et al.
BMC Nephrol
. 2024 Mar;
25(1):99.
PMID: 38493084
Background: Patient experiences and survival outcomes can be influenced by the circumstances related to dialysis initiation and subsequent modality choices. This systematic review and meta-analysis aimed to explore the rate...
3.
Blair C, Slee A, Davenport A, Fouque D, Johnston W, Kalantar-Zadeh K, et al.
Healthcare (Basel)
. 2022 Dec;
10(12).
PMID: 36553868
In this study, we aimed to develop a theoretical framework for a multimodal, integrative, exercise, anti-inflammatory and dietary counselling (MMIEAD) intervention for patients with renal cachexia with reference to how...
4.
Blair C, Shields J, Mullan R, Johnston W, Davenport A, Fouque D, et al.
PLoS One
. 2022 Nov;
17(11):e0277241.
PMID: 36327348
Renal cachexia is an important consideration in the person-centred care that is needed in end-stage renal disease (ESRD). However, given that clinical guidelines relating to renal cachexia are largely absent,...
5.
McKeaveney C, Slee A, Adamson G, Davenport A, Farrington K, Fouque D, et al.
Nephrol Dial Transplant
. 2021 Mar;
36(8):1554.
PMID: 33674859
No abstract available.
6.
OHalloran P, Noble H, Norwood K, Maxwell P, Murtagh F, Shields J, et al.
BMC Nephrol
. 2020 Nov;
21(1):478.
PMID: 33187506
Background: Advance Care Planning is recommended for people with end-stage kidney disease but evidence is limited. Robust clinical trials are needed to investigate the impact of advance care planning in...
7.
McKeaveney C, Slee A, Adamson G, Davenport A, Farrington K, Fouque D, et al.
Nephrol Dial Transplant
. 2020 Nov;
36(10):1919-1926.
PMID: 33150449
Background: Research indicates that cachexia is common among persons with chronic illnesses and is associated with increased morbidity and mortality. However, there continues to be an absence of a uniformed...
8.
McKeaveney C, Witham M, Alamrani A, Maxwell A, Mullan R, Noble H, et al.
BMJ Support Palliat Care
. 2020 Sep;
13(1):87-94.
PMID: 32917654
Objective: Consideration of quality of life (QoL) in people with end-stage renal disease has become an important part of treatment decision-making. The aim of this study was to report on...
9.
Slee A, McKeaveney C, Adamson G, Davenport A, Farrington K, Fouque D, et al.
J Ren Nutr
. 2019 Nov;
30(4):313-321.
PMID: 31734056
Objectives: Haemodialysis (HD) patients suffer from nutritional problems, which include muscle wasting, weakness, and cachexia, and are associated with poor clinical outcomes. The European Working Group for Sarcopenia in Older...
10.
OHalloran P, Noble H, Norwood K, Maxwell P, Shields J, Fogarty D, et al.
J Pain Symptom Manage
. 2018 Jul;
56(5):795-807.e18.
PMID: 30025939
Context: Patients with end-stage kidney disease have a high mortality rate and disease burden. Despite this, many do not speak with health care professionals about end-of-life issues. Advance care planning...